Literature DB >> 25946043

Deletion of 15q11.2(BP1-BP2) region: further evidence for lack of phenotypic specificity in a pediatric population.

Bita Hashemi1, Anne Bassett2, David Chitayat1,3, Karen Chong3, Mark Feldman4, Janine Flanagan5, Sharan Goobie6, Anne Kawamura7, Chelsea Lowther2, Chitra Prasad6, Victoria Siu6, Joyce So8,9,10, Sharon Tung11, Marsha Speevak12, Dimitri J Stavropoulos10, Melissa T Carter1.   

Abstract

Microdeletion of the BP1-BP2 region at 15q11.2 is a recurrent copy number variant (CNV) frequently found in patients undergoing chromosomal microarray (CMA). Genetic counselling regarding this CNV is challenging due to the wide range of phenotypic presentation in reported patients and lack of general population-based data. As one of the most common reasons for CMA is childhood developmental delay, clinicians need to be cognizant of the inherent ascertainment bias in the literature. We performed a detailed medical record review for 55 patients with this 15q11.2 microdeletion and report the clinical features of the 35 patients for whom information was available. We compared our results to the recent report by Cafferkey et al. in this journal. Our conclusion is that the phenotypic spectrum is too broad and non-specific to constitute a bona fide "syndrome" and that further research must be done to delineate the contribution of this CNV to phenotype.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  15q11.2; array CGH; autism; developmental delay; epilepsy; microdeletion

Mesh:

Year:  2015        PMID: 25946043     DOI: 10.1002/ajmg.a.37134

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage.

Authors:  Young Jae Woo; Alexandros K Kanellopoulos; Parisa Hemati; Jill Kirschen; Rebecca A Nebel; Tao Wang; Claudia Bagni; Brett S Abrahams
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

2.  Variable Penetrance of the 15q11.2 BP1-BP2 Microduplication in a Family with Cognitive and Language Impairment.

Authors:  Antonio Benítez-Burraco; Montserrat Barcos-Martínez; Isabel Espejo-Portero; Salud Jiménez-Romero
Journal:  Mol Syndromol       Date:  2017-04-14

Review 3.  The dilemma of diagnostic testing for Prader-Willi syndrome.

Authors:  Arabella Smith; Dorothy Hung
Journal:  Transl Pediatr       Date:  2017-01

Review 4.  Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.

Authors:  M G Butler
Journal:  J Intellect Disabil Res       Date:  2017-04-07

5.  Familial total anomalous pulmonary venous return with 15q11.2 (BP1-BP2) microdeletion.

Authors:  Yukiko Kuroda; Ikuko Ohashi; Takuya Naruto; Kazumi Ida; Yumi Enomoto; Toshiyuki Saito; Jun-Ichi Nagai; Sadamitsu Yanagi; Hideaki Ueda; Kenji Kurosawa
Journal:  J Hum Genet       Date:  2018-08-14       Impact factor: 3.172

6.  Evidence for the multiple hits genetic theory for inherited language impairment: a case study.

Authors:  Tracy M Centanni; Jordan R Green; Jenya Iuzzini-Seigel; Christopher W Bartlett; Tiffany P Hogan
Journal:  Front Genet       Date:  2015-08-24       Impact factor: 4.599

7.  Interstitial 6q21q23 duplication - variant of variable phenotype and incomplete penetrance or benign duplication?

Authors:  Malgorzata I Srebniak; Laura J C M van Zutven; Florence Petit; Sonia Bouquillon; Ilse P J van Heel; Maarten F C M Knapen; Jerome M J Cornette; Andreas Kremer; Diane Van Opstal; Karin E M Diderich
Journal:  Mol Cytogenet       Date:  2016-06-02       Impact factor: 2.009

8.  The importance of copy number variation in congenital heart disease.

Authors:  Gregory Costain; Candice K Silversides; Anne S Bassett
Journal:  NPJ Genom Med       Date:  2016-09-14       Impact factor: 8.617

9.  Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks.

Authors:  Rebecca A Nebel; Dejian Zhao; Erika Pedrosa; Jill Kirschen; Herbert M Lachman; Deyou Zheng; Brett S Abrahams
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

10.  Clinical Application of an Innovative Multiplex-Fluorescent-Labeled STRs Assay for Prader-Willi Syndrome and Angelman Syndrome.

Authors:  Kaihui Zhang; Shu Liu; Bing Feng; Yali Yang; Haiyan Zhang; Rui Dong; Yi Liu; Zhongtao Gai
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.